We represented AxelaCare Health Solutions, a leading provider of specialized immune globulin (IgG) therapy and other intravenous home infusion therapies, in its acquisition of ARC Infusion Corp based in Los Angeles. Terms of the transaction were not disclosed.

AxelaCare Health Solutions is a portfolio company of the New York-based private equity firm Harvest Partners.